Impatto della biopsia del linfonodo sentinella sul trattamento del melanoma.

Translated title of the contribution: Impact of sentinel lymph node biopsy on the treatment of melanoma

M. Santinami, M. Baldi, G. Tragni, A. Maurichi, D. Moglia, A. Bono, C. Bartoli, R. Patuzzo, E. Pennacchioli, N. Cascinelli

Research output: Contribution to journalArticle

Abstract

In the National Cancer Institute and S Pio X Hospital series we registered 981 patients with primary cutaneous melanoma and no evidence of clinically detectable regional node metastases underwent sentinel node (SN) dissection to microscopically define the tumor status of the regional lymph nodes. In 62.2% of cases, only one SN was detected; 26.4% of patients had two SNs and 11.4% had three or more SNs. A positive SNB was demonstrated in 18.1%. Analysis of survival indicated that the tumor status of the nodes was the most important prognostic factor. Breslow's thickness had a significant impact on survival in tumors of 4 mm or thicker, and ulceration dropped to a borderline significant P-value. To assess the tumor burden in positive SNB, all slides (148 SN pos) were reviewed. Twenty per cent of these patients had evidence of metastasis in other nodes. Of the remaining 80% with a single tumor-involved SN, 62% had a single metastatic deposit. Preliminary data from this study indicate that several subgroups may be identified among patients with 1 positive node, but adequate analysis of survival requires a larger number of patients and a multicentric study.

Original languageItalian
Pages (from-to)273-275
Number of pages3
JournalTumori
Volume89
Issue number4 Suppl
Publication statusPublished - Jul 2003

Fingerprint

Sentinel Lymph Node Biopsy
Melanoma
Survival Analysis
Neoplasms
Neoplasm Metastasis
Therapeutics
National Cancer Institute (U.S.)
Tumor Burden
Dissection
Lymph Nodes
Skin
Survival
cyhalothrin

ASJC Scopus subject areas

  • Cancer Research

Cite this

Santinami, M., Baldi, M., Tragni, G., Maurichi, A., Moglia, D., Bono, A., ... Cascinelli, N. (2003). Impatto della biopsia del linfonodo sentinella sul trattamento del melanoma. Tumori, 89(4 Suppl), 273-275.

Impatto della biopsia del linfonodo sentinella sul trattamento del melanoma. / Santinami, M.; Baldi, M.; Tragni, G.; Maurichi, A.; Moglia, D.; Bono, A.; Bartoli, C.; Patuzzo, R.; Pennacchioli, E.; Cascinelli, N.

In: Tumori, Vol. 89, No. 4 Suppl, 07.2003, p. 273-275.

Research output: Contribution to journalArticle

Santinami, M, Baldi, M, Tragni, G, Maurichi, A, Moglia, D, Bono, A, Bartoli, C, Patuzzo, R, Pennacchioli, E & Cascinelli, N 2003, 'Impatto della biopsia del linfonodo sentinella sul trattamento del melanoma.', Tumori, vol. 89, no. 4 Suppl, pp. 273-275.
Santinami, M. ; Baldi, M. ; Tragni, G. ; Maurichi, A. ; Moglia, D. ; Bono, A. ; Bartoli, C. ; Patuzzo, R. ; Pennacchioli, E. ; Cascinelli, N. / Impatto della biopsia del linfonodo sentinella sul trattamento del melanoma. In: Tumori. 2003 ; Vol. 89, No. 4 Suppl. pp. 273-275.
@article{9196e99a16ec46a69eefed81a62284a7,
title = "Impatto della biopsia del linfonodo sentinella sul trattamento del melanoma.",
abstract = "In the National Cancer Institute and S Pio X Hospital series we registered 981 patients with primary cutaneous melanoma and no evidence of clinically detectable regional node metastases underwent sentinel node (SN) dissection to microscopically define the tumor status of the regional lymph nodes. In 62.2{\%} of cases, only one SN was detected; 26.4{\%} of patients had two SNs and 11.4{\%} had three or more SNs. A positive SNB was demonstrated in 18.1{\%}. Analysis of survival indicated that the tumor status of the nodes was the most important prognostic factor. Breslow's thickness had a significant impact on survival in tumors of 4 mm or thicker, and ulceration dropped to a borderline significant P-value. To assess the tumor burden in positive SNB, all slides (148 SN pos) were reviewed. Twenty per cent of these patients had evidence of metastasis in other nodes. Of the remaining 80{\%} with a single tumor-involved SN, 62{\%} had a single metastatic deposit. Preliminary data from this study indicate that several subgroups may be identified among patients with 1 positive node, but adequate analysis of survival requires a larger number of patients and a multicentric study.",
author = "M. Santinami and M. Baldi and G. Tragni and A. Maurichi and D. Moglia and A. Bono and C. Bartoli and R. Patuzzo and E. Pennacchioli and N. Cascinelli",
year = "2003",
month = "7",
language = "Italian",
volume = "89",
pages = "273--275",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "4 Suppl",

}

TY - JOUR

T1 - Impatto della biopsia del linfonodo sentinella sul trattamento del melanoma.

AU - Santinami, M.

AU - Baldi, M.

AU - Tragni, G.

AU - Maurichi, A.

AU - Moglia, D.

AU - Bono, A.

AU - Bartoli, C.

AU - Patuzzo, R.

AU - Pennacchioli, E.

AU - Cascinelli, N.

PY - 2003/7

Y1 - 2003/7

N2 - In the National Cancer Institute and S Pio X Hospital series we registered 981 patients with primary cutaneous melanoma and no evidence of clinically detectable regional node metastases underwent sentinel node (SN) dissection to microscopically define the tumor status of the regional lymph nodes. In 62.2% of cases, only one SN was detected; 26.4% of patients had two SNs and 11.4% had three or more SNs. A positive SNB was demonstrated in 18.1%. Analysis of survival indicated that the tumor status of the nodes was the most important prognostic factor. Breslow's thickness had a significant impact on survival in tumors of 4 mm or thicker, and ulceration dropped to a borderline significant P-value. To assess the tumor burden in positive SNB, all slides (148 SN pos) were reviewed. Twenty per cent of these patients had evidence of metastasis in other nodes. Of the remaining 80% with a single tumor-involved SN, 62% had a single metastatic deposit. Preliminary data from this study indicate that several subgroups may be identified among patients with 1 positive node, but adequate analysis of survival requires a larger number of patients and a multicentric study.

AB - In the National Cancer Institute and S Pio X Hospital series we registered 981 patients with primary cutaneous melanoma and no evidence of clinically detectable regional node metastases underwent sentinel node (SN) dissection to microscopically define the tumor status of the regional lymph nodes. In 62.2% of cases, only one SN was detected; 26.4% of patients had two SNs and 11.4% had three or more SNs. A positive SNB was demonstrated in 18.1%. Analysis of survival indicated that the tumor status of the nodes was the most important prognostic factor. Breslow's thickness had a significant impact on survival in tumors of 4 mm or thicker, and ulceration dropped to a borderline significant P-value. To assess the tumor burden in positive SNB, all slides (148 SN pos) were reviewed. Twenty per cent of these patients had evidence of metastasis in other nodes. Of the remaining 80% with a single tumor-involved SN, 62% had a single metastatic deposit. Preliminary data from this study indicate that several subgroups may be identified among patients with 1 positive node, but adequate analysis of survival requires a larger number of patients and a multicentric study.

UR - http://www.scopus.com/inward/record.url?scp=0042380115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042380115&partnerID=8YFLogxK

M3 - Articolo

C2 - 12903619

AN - SCOPUS:0042380115

VL - 89

SP - 273

EP - 275

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 4 Suppl

ER -